Viatris Stock

Viatris Current Assets

The Current Assets of Viatris (VTRS) as of Aug 20, 2026 is 5.87 B USD. In the previous year, Current Assets was 9.52 B USD — a change of -38.30% (lower).

Current Assets

5.87 BUSD

YoY

-38.30%

Last updated:

Current Assets of Viatris is 2026 5.87 B USD. Current Assets of Viatris was 2025 9.52 B USD. It decreases by -38.30% lower compared to the previous year.
Access this data via the Eulerpool API

Viatris Stock analysis

What does Viatris do? Viatris Inc. is a global pharmaceutical company that was formed in 2020 through the merger of Mylan and Upjohn. Headquartered in Pennsylvania, USA, the company operates in over 165 countries. Viatris is one of the largest generic and biosimilar manufacturers worldwide. Viatris is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Viatris stock

Current Assets of Viatris is 5.87 B USD in 2026.

Current Assets of Viatris changed from 9.52 B USD to 5.87 B USD, representing a -38.30% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Current Assets Viatris since 2006 – with annual values, charts, and detailed analysis.

Current assets are assets expected to be converted to cash within one year, including cash, receivables, and inventory.

Current Assets's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Assets's Viatris historically and in real time.

Access this data via the Eulerpool API

Balance Sheet — Viatris

All Key Metrics — Viatris